Use of Norethindrone Acetate for Management of Bleeding Associated With the Etonogestrel Contraceptive Implant

• Status: Unknown status
• Trial end date: 2018-11-01
• Target enrollment: 0
• Participant gender: Female

Summary

The overall objective of this study is to confirm that oral progesterone is an effective way to manage bothersome bleeding; thus increasing the rate of continuation of the etonogestrel contraceptive implant in adolescents.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Norton Healthcare
• Treatments: Contraceptive Agents; Etonogestrel; Norethindrone; Norethindrone Acetate

Criteria

Inclusion Criteria:

• Inclusion criteria will include any post---menarchal female presenting to the Kosair Children's Hospital Gynecologic Specialist practice, who desires to use the etonogestrel contraceptive implant and has access to a mobile phone device.

Exclusion Criteria:

• NA